The stock market showed mixed signals today, characterized by Pfizer exceeding earnings expectations by $0.14 per share, which contributed positively to…
https://newsstocks.live/analysis/pfizer-leads-with-earnings-beat-sp-gains-023 #Finance #Markets
The stock market showed mixed signals today, characterized by Pfizer exceeding earnings expectations by $0.14 per share, which contributed positively to…
https://newsstocks.live/analysis/pfizer-leads-with-earnings-beat-sp-gains-023 #Finance #Markets
Pfizer (PFE) reported earnings that exceeded analyst expectations by $0.14 per share. The company also posted revenue figures …
https://newsstocks.live/news/pfizer-pfe-beats-earnings-by-014-and-tops-revenue-estimates #Finance #Markets
Pfizer (PFE) reported earnings that exceeded analyst expectations by $0.14 per share. The company also posted revenue figures …
https://newsstocks.live/news/pfizer-pfe-beats-earnings-by-014-and-tops-revenue-estimates #Finance #Markets
Hey Buddy…
Funny her husband’s Pfizer bond holding drew scrutiny because she serves on a Senate committee with health-policy jurisdiction.
Now, that is a plausible appearance-of-conflict concern,
www.washingtonsun.com/senate/susan...
Hey Buddy…
Funny her husband’s Pfizer bond holding drew scrutiny because she serves on a Senate committee with health-policy jurisdiction.
Now, that is a plausible appearance-of-conflict concern,
www.washingtonsun.com/senate/susan...
Pfizer reported third-quarter 2026 revenue of $16.6 billion and adjusted diluted earnings per share (EPS) of $0.87. Total revenue fell $71 million from the year-ago period. The company noted 7% operational…
#stocks #investing
Pfizer reported third-quarter 2026 revenue of $16.6 billion and adjusted diluted earnings per share (EPS) of $0.87. Total revenue fell $71 million from the year-ago period. The company noted 7% operational…
#stocks #investing
replaye.com/pfizer-hikes...
#News #Pfizer #CFO #Investing #Business
replaye.com/pfizer-hikes...
#News #Pfizer #CFO #Investing #Business
Pfizer beat third quarter forecasts, lifted its 2026 revenue and profit outlook and confirmed Cecile Guegan as chief financial officer.
Pfizer beat third quarter forecasts, lifted its 2026 revenue and profit outlook and confirmed Cecile Guegan as chief financial officer.